Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-3,page-paged-3,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.4.2,vc_responsive

CLIENT NEWS

 

 

  • XPhyto Partner Receives ISO Certification for 25-Minute COVID-19 RT-PCR Test
    10 March 2021
    www.xphyto.com
  • Abivax follows DSMB recommendation to stop the phase 2b/3 miR-AGE Covid-19 clinical trial due to lack of efficacy
    08 March 2021
    www.abivax.com
  • Relief Increases Issued Share Capital with Creation of Treasury Shares
    08 March 2021
    www.relieftherapeutics.com
  • CENTOGENE GmbH: CENTOGENE und die Stadt Rostock starten Pilotprojekt zur sicheren Schulöffnung durch regelmäßige SARS-CoV-2-PCR-Testungen der gesamten Schüler- und Lehrerschaft der Region
    04 March 2021
    www.centogene.com
  • XPhyto Completes Corporate Rebranding and Launches New Website
    04 March 2021
    www.xphyto.com
  • InflaRx to Present at Upcoming Investor Conferences
    03 March 2021
    www.inflarx.de
  • Vroni-Studie zur Früherkennung von Familiärer Hypercholesterinämie bei Schulkindern ermöglicht nun auch Testung auf Antikörper gegen SARS-CoV-2
    03 March 2021
    www.dhm.mhn.de
  • ABIVAX publishes data of ABX464 induction and long-term maintenance phase 2A ulcerative colitis study in the jounal “Gastroenterology”
    03 March 2021
    www.abivax.com
  • Molecular Health and FALCO biosystems team up to provide genetic analysis services using MH Guide/BRCA and MH Guide/Mendel
    02 March 2021
    www.molecularhealth.com
  • InflaRx Announces Closing of $75 Million Public Offering of Common Shares and One-Year Warrants
    01 March 2021
    www.inflarx.de